Effectiveness and Safety of New Oral Antivirals for COVID-19

NCT05894603 · clinicaltrials.gov ↗

UNKNOWN

Status

211

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Nirmatrelvir/ritonavir
DRUG: Molnupiravir

Sponsor

Universidade do Porto

Collaborators

[object Object]
[object Object]